Skip to content

Clinical trials

Phase 3 Hypercholesterolemia trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 3 Country / region: Italy Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20061
20091
20111
20124
20136
20142
20152
20163
20181
20211
20233
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting4
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen11
Sanofi4
Kowa Research Europe3
Merck Sharp & Dohme LLC3
Novartis Pharmaceuticals3
Regeneron Pharmaceuticals3
Aegerion Pharmaceuticals, Inc.1
Daiichi Sankyo1
Kastle Therapeutics, LLC1
Mario Negri Institute for Pharmacological Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia31
Dyslipidemias8
Hyperlipidemias6
Hyperlipoproteinemia Type II5
Cardiovascular Diseases3
Coronary Artery Disease2
Diabetes Mellitus2
Homozygous Familial Hypercholesterolemia2
Aortic Valve Stenosis1
Arteriosclerosis1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.